Suchergebnisse - "Chakraborty, Santam"

PubPharm (82)

21

Consensus on contentious issues relevant for breast cancer management for the Indian scenario : Statements following a multicentre expert group meeting

enthalten in: The Indian journal of medical research | 2021

von Chatterjee, S. | Chakraborty, S. | Controversies to Consensus Author Group

22

Integrating The Boost: Development Of A Hybrid Volumetric Modulated Arc Based Simultaneous Integrated Boost Class Solution For Breast Cancer

enthalten in: ResearchSquare.com | 2021

von Chatterjee, S. | Mahata, A. | Mandal, S. | +1

23

State of use of Electronic Data Capture (EDC) tools in randomized controlled trials in India: results from a survey

enthalten in: ResearchSquare.com | 2021

von Chakraborty, S. | Mallick, I. | Bhattacharyya, T. | +3

24

Real-world results of definitive chemoradiation in carcinoma oesophagus : can SCOPE1 results be replicated outside trial setting?

enthalten in: Ecancermedicalscience | 2021

von Bhattacharyya, T. | Harilal, V. | Sashidharan, R. | +5

25

Geographic disparities in access to cancer clinical trials in India

enthalten in: Ecancermedicalscience | 2021

von Chakraborty, S. | Mallick, I. | Luu, H. | +4

26

Can the CROSS protocol be safely implemented in real world scenario with broader eligibility criteria? Experience from a tertiary care centre in India

enthalten in: Ecancermedicalscience | 2021

von Bhattacharyya, T. | Arunsingh, M. | Chakraborty, S. | +9

27

Not so 'rare'-an example of malignant melanoma in India : report from a tertiary cancer centre

enthalten in: Ecancermedicalscience | 2021

von Biswas, B. | Biswas, G. | Ganguly, S. | +10

28

Prioritizing Delivery of Cancer Treatment During a COVID-19 Lockdown : The Experience of a Clinical Oncology Service in India

enthalten in: JCO global oncology | 2021

von Mallick, I. | Chakraborty, S. | Baral, S. | +18

29

Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer : an open-label randomized controlled study (HYPORT-Adjuvant)-study protocol for a multicentre, randomized phase III trial

enthalten in: Trials | 2020

von Chatterjee, S. | Chakraborty, S. | HYPORT Adjuvant Author Group | +17

30

Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial

enthalten in: Trials | 2020

von Chatterjee, S. | Chakraborty, S.